Tags: AF | South Africa | HIV Vaccine Trial

New HIV Vaccine Trial to Start in South Africa

Sunday, 27 November 2016 09:50 AM

JOHANNESBURG (AP) — Scientists say a new vaccine against HIV, to be tested in a trial to be launched in South Africa this week, could be "the final nail in the coffin" for the disease if it is successful.

Anthony Fauci, director of the U.S. government's National Institute of Allergy and Infectious Diseases (NIAID), said Sunday, in a statement released ahead of the trial, said the new vaccine is promising.

The study, called HVTN 702, is to begin Wednesday and aims to enroll 5,400 sexually active men and women aged between 18 and 35 at 15 sites across South Africa.

It will be the largest and most advanced HIV vaccine clinical trial to take place in South Africa, where more than 1,000 people a day are infected with HIV.

© Copyright 2019 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

   
1Like our page
2Share
Africa
Scientists say a new vaccine against HIV, to be tested in a trial to be launched in South Africa this week, could be "the final nail in the coffin" for the disease if it is successful.Anthony Fauci, director of the U.S. government's National Institute of Allergy and...
AF,South Africa,HIV Vaccine Trial
128
2016-50-27
Sunday, 27 November 2016 09:50 AM
Newsmax Media, Inc.
 
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved